Navigation Links
Asthmapolis Expands Dignity Health Study to Include Mercy Medical Group Patients
Date:8/6/2012

MADISON, Wis., Aug. 6, 2012 /PRNewswire/ -- Asthmapolis announced today that it will be expanding its asthma study at Woodland Healthcare in Woodland, Calif. to also include patients from Mercy Medical Group, another Dignity Health system, located in neighboring Sacramento, Calif.

"We're excited to expand the study to include the patients and physicians at Mercy Medical Group," noted David Van Sickle, co-founder and CEO of Asthmapolis. "With the addition of this system, thousands of additional individuals in Sacramento will now be eligible to participate in a free program to better understand and manage their asthma."

Dignity Health, formerly Catholic Healthcare West, is the fifth largest healthcare system in the United States. The Asthmapolis study is part of the organization's comprehensive, integrated clinical care model created to improve the lives of adults and children with chronic disease by reducing cost, expanding access and improving quality of care. "This is a tremendous opportunity to work with a state-of-the-art technology to improve the health of our patients," stated S. Rubina Inamdar, M.D., Head, Division of Allergy and Immunology at Mercy Medical Group. 

Study participants will be equipped with the Asthmapolis inhaler sensor, which sits on top of inhalers that are used to relieve symptoms in the event of an asthma attack. When an inhaler is used, the sensor works with the participant's cell phone to transmit the time and location of the attack to the company's computer network.

The study is open to both English and Spanish-speaking patients, and there is no enrollment cost. Participants will be compensated $25 upon enrollment, and those who complete the study will be entered in a drawing to win $500.

The Asthma and Allergy Foundation of America (AAFA) rates Sacramento as one of the most challenging cities to live with asthma, with worse than average air quality. In May, the area experienced an asthma
'/>"/>

SOURCE Asthmapolis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor Technology and Accompanying Software System
2. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
3. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
4. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
5. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
6. S1 Biopharma Expands Focus to Include Male Sexual Health
7. PRA Expands Operations in Europe
8. USANA Health Sciences Expands Award-Winning Research and Development Team
9. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
10. Argus Expands Specialty Pharmacy with Amber Pharmacy Collaboration
11. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... WESTFORD, Mass. , July 30, 2014 ... in laser- and light-based aesthetic treatments for non-invasive and minimally ... promoted Executive Vice President, Chief Operating Officer and Chief Financial ... Company, effective August 1, 2014.  Baker, 53, will continue to ... from Michael Davin , who remains Chairman and Chief ...
(Date:7/30/2014)... and SAN DIEGO , July 30, 2014 ... ARNA ) announced today that an article based on post-hoc ... entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise ... published in the online issue of Obesity , the ... of these analyses was to identify whether there is an ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... Jude scientists, findings in ataxia telangiectasia-like disease ... the links between brain disease and cancer ... Jan. 14 Scientists at ... apart the biological details distinguishing two related ...
... VALENCIA, Calif., Jan. 13 MannKind Corporation ... of its trial to demonstrate equivalence of its commercial ... used in clinical trials to deliver AFRESA(TM), MannKind,s ultra ... trials. Study 138 - Bioequivalence of Clinical and ...
Cached Medicine Technology:Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 2Study Shows How Defective DNA Repair Triggers Two Neurological Diseases 3MannKind Reports Successful Completion of Device Bioequivalence Trial 2MannKind Reports Successful Completion of Device Bioequivalence Trial 3
(Date:7/30/2014)... (PRWEB) July 30, 2014 The family ... bleeding has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ... thinner, Bernstein Liebhard LLP reports. According to the complaint, ... District of Vermont on July 25th, the decedent had ... suffered an irreversible brain bleed that ultimately led to ...
(Date:7/30/2014)... Hawley, Pennsylvania (PRWEB) July 30, 2014 ... and have contributed over $8,500 to ensure its protection. ... Resort, presents a check to the Delaware Highlands Conservancy ... Partnership program. The small $2-per-stay donations add up fast, ... future of the Upper Delaware River Region. , The ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Some obese people ... the reward centers in their brains when they see ... how this mutation triggers feelings of pleasure and gratification ... help improve strategies designed to prevent overeating, the scientists ... obese. Obesity is typically caused by a combination ...
(Date:7/30/2014)... KY (PRWEB) July 30, 2014 DRE ... pleased to announce the launch of its Medical ... online resource for medical professionals and equipment vendors. , ... shows and conventions in the United States and around ... the calendar, and that number is always growing. , ...
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed people ... published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. Brennan Spiegel interviewed ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Gene Mutation May Make Food More Tempting 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3
... Increased 74.0% to $59.0 Million in 2Q08 -- ... Increased 43.4% to $13.9 Million -- ... EPS $0.15 --, NEW YORK, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- ... dedicated to,improving health through the development, manufacture and commercialization,of a ...
... of $17.9 Million Treatment Tip and Other Consumables Revenue Up ... ... Thermage, Inc.,(Nasdaq: THRM ), a leader in non-invasive tissue tightening ... ended,June 30, 2008., Revenue for the second quarter of 2008 totaled ...
... may provide context for tumor formation, new treatments ... more about normal cells that give rise to cancer ... according to Duke University Medical Center researchers who identified ... "Identifying the specific, normal cells that cancer come from ...
... more common, study finds , , MONDAY, Aug. 11 ... adults don,t have the 20/20 vision physicians consider ... an irregular corneal curve known as astigmatism, a ... that such common eye-focus problems -- collectively known ...
... fewer disabilities, study finds , , MONDAY, Aug. 11 (HealthDay News) ... -- and even the creeping ravages of time -- at ... found that older runners live longer and suffer fewer disabilities ... to a variety of aerobic exercises, including walking, said the ...
... (August 11, 2008) Scientists from the University of ... people who develop Alzheimer,s disease may show signs of ... educational achievement. Their research appears online this month in ... , Participants in the Nun Study were studied to ...
Cached Medicine News:Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 2Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 3Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 4Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 5Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 6Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 7Health News:American Oriental Bioengineering Reports Second Quarter 2008 Financial Results 8Health News:Thermage Announces Second Quarter 2008 Financial Results 2Health News:Thermage Announces Second Quarter 2008 Financial Results 3Health News:Thermage Announces Second Quarter 2008 Financial Results 4Health News:Thermage Announces Second Quarter 2008 Financial Results 5Health News:Thermage Announces Second Quarter 2008 Financial Results 6Health News:Thermage Announces Second Quarter 2008 Financial Results 7Health News:Thermage Announces Second Quarter 2008 Financial Results 8Health News:Thermage Announces Second Quarter 2008 Financial Results 9Health News:Researchers Hunt Normal Cells That Give Rise to Cancer 2Health News:Half of U.S. Adults Lack 20/20 Vision 2Health News:Half of U.S. Adults Lack 20/20 Vision 3Health News:Run for Your Life 2Health News:Run for Your Life 3Health News:Signs of Alzheimer's disease may be present decades before diagnosis 2
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
... The TheraSeed® Pd-103 implant is a combination ... remarkable visibility that makes TheraSeed® treatment an ... can be confident that every TheraSeed® implant ... services which is required by clinicians who ...
... Bard BrachyStar® Needle is designed to help ... and clinically effective brachytherapy procedure. All needles ... tips and polished surfaces for smooth entry ... configurations and sizes assures an ideal match ...
... is designed to help you achieve one ... brachytherapy procedure. All needles are engineered for ... surfaces for smooth entry and exit. A ... assures an ideal match with procedural needs ...
Medicine Products: